To assess the clinical relevance of this finding, we performed an immunohistochemical examination of the protein levels of V-ATPase V1E1 and p-PKM2 in cancer tissues from a distinct ESCC cohort (n = 302) (Supplementary Table S1). The gene discussed is PKM; the disease is esophageal squamous cell carcinoma.